By Central OC Times |
May 28, 2024
A multidisciplinary research team at the University of California, Irvine has discovered that the circadian clock can be utilized to enhance the efficacy of checkpoint inhibitor cancer therapy. This biological pacemaker governs daily rhythms in physiological processes, including immune functions. The study, published in Nature Immunology, highlights the potential of optimizing time-of-day delivery based on individual circadian patterns for improved prevention and treatment.